6:15 PM
Dec 18, 2012
 |  BC Extra  |  Company News

Navidea seeking EU approval for Lymphoseek

Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB) submitted an MAA to EMA for Lymphoseek tilmanocept for use in intraoperative lymphatic imaging. Navidea said...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >